Supplement Industry Daily Briefing: June 01, 2026
Key Takeaways
- The Gummy-ification Wave: Unilever's $1.2 billion acquisition of Grüns highlights the explosive growth of gummy formats, sparking intense debate with industry leaders like AG1 over nutrient density versus convenience.
- GLP-1 Companion Strategy: The supplement sector is shifting from weight-loss competition to companion products, focusing on nutrient gaps and muscle preservation for long-term GLP-1 users.
- Modernizing FDA Oversight: The FDA's Human Foods Program is prioritizing technology, AI, and collaborative auditing to modernize supplement regulation, triggering discussions on industry user fees.
- Clinical Efficacy Focus: New human trials on lychee polyphenol (Oligonol) and specialized marine oils (EPAX Cetoleic 2040) are setting higher scientific standards for product claims.
Top Stories
The global dietary supplement industry is witnessing a massive format battle as traditional greens powders defend their territory against the rapid "gummy-ification" of wellness. Unilever's recent acquisition of Grüns, a greens gummy brand, for a reported $1.2 billion highlights the explosive growth of candy-like delivery formats. Meanwhile, AG1 CEO Kat Cole has publicly critiqued the gummy format, arguing that it is biochemically impossible to fit the comprehensive nutrition of a greens powder scoop into a gummy without compromising efficacy. This tension highlights a critical decision point for supplement brands between consumer adherence and formulation potency.
In response to the massive adoption of GLP-1 weight loss therapies, the supplement industry is rapidly shifting its marketing and formulation strategies. Rather than attempting to mimic or compete directly with these pharmaceutical blockbusters, manufacturers are developing companion supplements aimed at addressing common side effects, such as nutrient deficiencies and muscle preservation. Industry experts suggest that because obesity is a chronic condition and weight regain is common after drug discontinuation, long-term nutritional support for GLP-1 users represents a highly sustainable market opportunity.
The United States Food and Drug Administration (FDA) has announced a major initiative to "modernize" dietary supplement regulation as a top priority for its Human Foods Program. The agency intends to leverage artificial intelligence, advanced data analytics, and third-party audit data to improve risk prioritization and inspection coverage. This shift toward a smarter, more collaborative regulatory environment is sparking debate among industry stakeholders, particularly regarding potential user fees to fund stronger enforcement against bad actors while protecting responsible innovation.
Business and Investment
Investment activity in the wellness sector remains robust, with a strong focus on plant-based nutrition, biotechnology, and high-value ingredient processing. Axum Capital Partners has completed a strategic investment in VitaHustle, a plant-based protein and functional wellness brand co-founded by Kevin Hart, aligning with shifting consumer demand toward clean-label, performance-driven nutrition.
In the biotechnology space, Phytolon has successfully closed a $23.6 million Series B funding round to commercialize its fermentation-based natural food colors in the United States. This milestone follows the FDA's approval of Beetroot Red, the company's first natural colorant, which offers a sustainable, high-purity alternative for clean-label food and supplement manufacturing.
On the manufacturing infrastructure front, dairy giant FrieslandCampina has announced a 90 million euro investment to upgrade its production sites in the Netherlands. The capital will be used to manufacture advanced, high-value whey protein products like WPC80 and microparticulated whey, addressing the accelerating global demand for specialized sports nutrition and active aging formulations.
Science and Research
Clinical validation is becoming the primary differentiator for premium supplement brands as consumers demand evidence-backed efficacy. A new human clinical study published on Maypro's Oligonol, a low molecular weight lychee fruit polyphenol, demonstrated significant improvements in athletic endurance. Middle-aged long-distance runners taking 200 mg of Oligonol daily for 60 days showed a significant increase in running distance and reduced perceived exertion compared to the placebo group, suggesting enhanced energy metabolism and fatigue resistance.
Cardiovascular research is also advancing with a groundbreaking study conducted by the University of Bergen on Epax Norway's new marine oil, EPAX Cetoleic 2040. The clinical trial revealed that supplementation with these specialized marine long-chain monounsaturated fatty acids (Omega-9 Gondoic acid and Omega-11 Cetoleic acid) reduced LDL-cholesterol in overweight and obese adults by 7% over eight weeks, which is estimated to lower coronary heart disease risk by 15%.
| Study Ingredient | Research Institution | Daily Dosage | Key Health Outcome |
|---|---|---|---|
| Oligonol (Lychee Polyphenol) | Maypro / Amino Up | 200 mg | Improved running distance and reduced perceived exertion in runners |
| EPAX Cetoleic 2040 (Marine Oil) | University of Bergen | Clinical dose | 7% reduction in LDL-cholesterol in overweight adults |
New Product Launches and Formulation
The product development landscape is characterized by a transition from generic ingredients to highly targeted, life-stage-specific formulations. Promino Nutritional Sciences has announced the launch of its new direct-to-consumer platform, Drink Rej, to scale its proprietary, plant-based amino acid formula designed to support muscle protein synthesis without the calories or dairy associated with traditional proteins.
In the prenatal and maternal wellness category, UK-based brand Rheal has launched Pregnancy + New Mama, its first dedicated pre- and postnatal supplement. Developed using highly bioavailable, clean ingredients, the formulation aims to address the common trust deficit in maternal nutrition by eliminating poorly absorbed synthetic nutrients.
Additionally, the contract manufacturing sector is adapting to these formulation trends. Liquid-first CDMO TOSLA is leading a shift toward liquid dietary supplements by utilizing its proprietary VELIOUS™ Flavour Technology. This innovation allows for the creation of sugar-free liquid supplements that effectively mask the bitter off-notes of active botanicals, enhancing consumer adherence and taste experience.
Regulations and Quality
Regulatory enforcement and quality assurance remain top priorities as the industry navigates safety challenges. The FDA and CDC are currently conducting a joint outbreak investigation of Salmonella infections linked to contaminated moringa leaf powder. This has resulted in a voluntary recall of Why Not Natural Pure Organic Moringa Green Superfood capsules and Live it Up brand Super Greens powder, highlighting the critical necessity of rigorous raw material testing.
Additionally, Total Nutrition Inc. has initiated a voluntary recall of its TNVitamins and Doctor's Pride Ultra Potent Complete Green Superfood dietary supplements due to quality discrepancies. These recalls underscore the importance of robust Good Manufacturing Practices (GMP) and supplier qualification programs.
Conversely, forward-thinking manufacturers are proactively securing advanced quality certifications. Contract manufacturer Icelandirect has achieved the prestigious FSSC 22000 certification. This internationally recognized food safety standard reinforces the company's commitment to the highest levels of quality control and supply chain transparency in supplement manufacturing.
Marketing and Consumer Trends
Marketing strategies are shifting heavily toward education and influencer-led transparency. Ingredient manufacturer Balchem has launched a new consumer awareness campaign, partnering with social media influencers and dermatologists to directly educate the public on the benefits of branded ingredients like OptiMSM.
This educational focus is increasingly critical as brands navigate the GLP-1 weight loss boom. Rather than marketing weight loss supplements as direct alternatives, brands are successfully positioning companion products that support overall vitality, metabolic health, and lean muscle preservation during rapid weight loss.
About the Author
Ben Law is the Founder of Love Life Supplements, a premium UK-based nutritional brand dedicated to providing clean, high-quality, and clinically backed dietary supplements. With years of experience in the wellness and fitness industry, Ben is passionate about simplifying nutrition and helping individuals achieve optimal health through clean supplementation and science-backed education. Learn more about Ben and his mission on the Ben Law - Founder page.